Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Meta-Analysis Studies — Once The Holy Grail For Doctors, Now Skewed By Money And Interests

October 19, 2016 By Meagan Parrish

For years, doctors have often turned to meta-analyses to make sense of conflicting research.

Considered the highest form of scientific analysis, these summary studies use meticulous statistical research to synthesize the current literature and give the most comprehensive final word on a given topic.

Yet, recent reports have begun to reveal the pitfalls of this kind of research — leaving many to wonder if there’s any kind of scientific study you can trust.

One researcher in particular — John Ioannidis — has been sounding the alarm that meta-analysis can easily be full of hidden biases and conflicts of interest.  

According to a report in Quartz, Ioannidis’ most recent study of meta-analysis led him to conclude that “the large majority of produced systematic reviews and meta-analyses are unnecessary, misleading, or conflicted.”

One of the forces pushing the research world toward skewed research is the pressure to publish quickly and often. For example, Ioannidis looked at a group of studies involving antidepressant drugs.

“There are 185 of them published in the literature within seven years, which means about 25 of them published every year for the very same drugs and the very same indication, major depression,” Ioannidis said in a recent NPR report.

And like other scientific studies, Ioannidis argues that the authors of meta-analysis often have financial interests tied to the outcome of the research.

After examining those 185 systematic reviews on antidepressants, Ioannidis found that among the 58 that included a negative statement about the drugs, only one had an author who worked at a pharmaceutical company at the time. All told, when an industry author contributed to a meta-analysis, it was 22 times less likely to generate a negative outcome about the drug.

And when authors have a bias, they can not only set up the study to get the answer they want, they can also bury negative information, such as side effects for drugs.

Peter Kramer, a professor interviewed by NPR, also blames ideological biases as a reason a study can become tainted. For example, he said he’s seen biases in academics working on studies about antidepressants who already believe placebos are just as useful for patients.

What’s being done to improve the situation?

Groups like the AllTrials initiative are pushing for greater transparency in the research community by getting pharmaceutical companies and health organizations to publish trials regardless of the outcome. The UN is also pressuring governments to ensure all clinical trial results are made public.

Ioannidis has also pitched the idea of making meta-analysis reviews living documents, like Wikipedia pages, that researchers can update and manage.

But for now, it’s partially up to doctors to read between the lines of every study — including meta-analyses — to understand the biases that could be distorting the bottom line. 

Related Articles Read More >

A photo of Capstan Medical's mitral valve implant, which uses nitinol.
Capstan Medical’s R&D head discusses the heart valve and robotics startup’s tech, engineering challenges and solutions, advice for others in medtech and how to join his team
An illustration of a neurosurgeon using a robotic endoscope to remove a brain tumor.
MDO Nitinol Innovation Special Report
A photo of Highridge Medical CEO Rebecca Whitney.
Highridge Medical is betting on this spine tech
An illustration showing the Artedrone Sasha thrombectomy catheter approaching a blood clot.
This microrobot system is designed to float inside a stroke patient for autonomous thrombectomy
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe